Are animal models still relevant to drug development?
Adèle Bouyer reviews how a recent change in FDA regulation may herald a decline in animal testing, in the face of new alternative models.
Adèle Bouyer reviews how a recent change in FDA regulation may herald a decline in animal testing, in the face of new alternative models.
Ilke Boran argues that there may be much to be gained from space exploration, as long as the benefits are made available to all.
Sophie Beaumont reviews research into how the blood-brain barrier protects the brain, and poses challenges for delivery of medical treatment.
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .
Paris Jaggers describes the surprising environmental legacy of nuclear fallout from the bomb testing era of the mid-20th century.
Helen Collins explores evidence for and against Dunbar’s number, the idea that our species’ social groups are limited to around 150 people.
Nell Miles argues that as a crucial and often-forgotten part of soil biodiversity, fungi deserve more research and recognition.
Jessye Phillips argues we shouldn’t give in to simplistic views of genetic engineering – it has great potential to tackle climate change.
Manaal Khan describes the potential future of medicine, electronics, and industry in the face of new small-scale science and nanotechnology.
OpenAI’s language model ChatGPT describes itself, how it was created, and its significance in the field of natural language processing and AI.